Why Post-Claim Rules Matter as Much as the Claim Itself

Most guides on the UAE R&D Tax Credit focus on eligibility: which activities qualify, which costs count, how the tiered rate is calculated. Far less attention is paid to what happens after the credit is claimed. Yet Articles 5 through 7 and 15 through 16 of Ministerial Decision No. 24 of 2026 create a set of post-claim rules that can unwind years of accrued credits — with significant financial and penalty consequences.

Understanding these rules is not merely academic. For any UAE business that has claimed or plans to claim the R&D Tax Credit, they create ongoing compliance obligations that must be factored into corporate planning decisions — including ownership transactions, business restructurings, regime elections and group reorganisations. Fastlane's Corporate Tax advisory team provides forward-looking risk assessments specifically for this purpose.

Article 5: Carry-Forward Conditions — Ownership Continuity or Same Business Activity

Where a Qualifying Entity's R&D Tax Credit exceeds its Corporate Tax and/or Top-up Tax liability in a given tax period, the unutilised credit does not expire — it is available to carry forward to future tax periods as the Available R&D Tax Credit. However, the right to carry forward is conditional. Article 5 of Ministerial Decision No. 24 of 2026 establishes two alternative conditions that must be satisfied to preserve carry-forward credits across an ownership change.

Article 5

The Two Carry-Forward Conditions

For a Qualifying Entity to carry forward an R&D Tax Credit that arose in a prior period, at least one of the following two conditions must be satisfied at the time the credit is utilised:

Condition A — Ownership Continuity: The same person or persons who held at least 50% ownership of the Qualifying Entity at the end of the tax period in which the credit arose still hold that ownership interest at the end of the tax period in which the credit is utilised. In other words, ownership has not changed by more than 50% since the credit was earned.

Condition B — Same Business Activity: Where ownership has changed by more than 50%, the Qualifying Entity continues to carry on the same or a similar business activity at the end of the tax period in which the credit arose and at the end of the tax period in which it is utilised.

Failing both conditions means the carried-forward credit is lost for that utilisation period. The credit is effectively stranded — it cannot be applied against CT liability and cannot be transferred.

📈 Exception: Listed Companies Are Exempt from Condition A

Where a Qualifying Entity is listed on a Recognised Stock Exchange — defined under the UAE CT Law — it is exempt from the ownership continuity condition (Condition A). A listed entity may carry forward its R&D Tax Credit regardless of how its shareholder register changes, provided it continues to satisfy the business activity condition or remains listed throughout the relevant period.

What "Same or Similar Business Activity" Means

The concept of "same or similar business activity" is not defined with bright-line precision in the Ministerial Decision, which means the FTA may take a fact-specific view. Businesses that have changed their principal commercial activities — pivoted their model, entered entirely new sectors or exited their core R&D-intensive operations — are at greatest risk of failing Condition B. Conversely, an entity that has undergone an ownership change but continues to operate the same R&D-driven commercial activities in the same market is in a much stronger position. Early documentation of business continuity is essential, and Fastlane's accounting and tax advisory team maintains the contemporaneous records needed to support this analysis.

Article 6: Transferring the Credit to Commonly Owned Entities

Article 6 introduces a credit transfer mechanism that allows a Qualifying Entity to transfer all or part of its Available R&D Tax Credit to another entity — but with significant restrictions on what the receiving entity can do with it.

Article 6

Credit Transfer Rules

Who can receive a transfer: The transferee must be an entity that is at least 75% commonly owned with the Qualifying Entity (the transferor) at the time of the transfer. This 75% threshold is stricter than the 50% threshold used in the carry-forward ownership continuity condition.

Transferee restrictions — two critical limits:

(1) No carry-forward by the transferee: The transferred credit cannot be carried forward by the receiving entity. The transferee must use the credit in the tax period in which it is received, or lose it. This is a sharp contrast to the transferor's own credits, which may be carried forward subject to Article 5 conditions.

(2) No re-transfer by the transferee: The receiving entity cannot re-transfer the credit to any further party. The credit can only move once — from the original Qualifying Entity to the first-level transferee.

Effect on the transferor: The Qualifying Entity's Available R&D Tax Credit is reduced by the amount transferred. The transfer is not reversible once made.

⚠️ The Transfer is a One-Shot, Use-It-or-Lose-It Mechanism

  • The transferee must apply the credit in the same tax period it is received
  • There is no mechanism for the transferee to carry forward what it receives
  • Re-transfer from the transferee to a further entity is prohibited
  • The 75% ownership test must be satisfied at transfer date — plan timing carefully
  • The transferor permanently loses the transferred amount from its Available R&D Tax Credit

Article 7: Business Restructuring — The 2-Year Continuation Requirement

Article 7 governs what happens when a Qualifying Entity that has benefited from the R&D Tax Credit undergoes a business restructuring. The central rule is a mandatory 2-year post-restructuring continuation requirement. The consequences of failing it are among the most severe in the entire Ministerial Decision.

Article 7

Post-Restructuring Activity Continuation

The requirement: A Qualifying Entity that benefits from the R&D Tax Credit must continue the qualifying R&D activities for a minimum of two years following the completion of a business restructuring.

Where a transferee takes over: If the R&D activities are transferred to another entity as part of the restructuring, that transferee inherits the 2-year continuation obligation. The obligation follows the activities, not just the original entity.

What "business restructuring" covers: The Ministerial Decision references business restructurings as defined in Article 27 of Federal Decree-Law No. 47/2022 — mergers, acquisitions, demergers, transfers of business and other forms of reorganisation that would otherwise qualify for relief from the CT Law's standard realisation rules.

Consequences of Failing the 2-Year Continuation Requirement

If qualifying R&D activities are discontinued within two years of a business restructuring by either the original entity or its transferee, the consequences are comprehensive and financially punishing:

🚨 Article 7 Claw-Back Consequences — All Four Apply Simultaneously

  • Repayment of utilised credit: Any R&D Tax Credit that was already applied against Corporate Tax or Top-up Tax must be repaid in full to the FTA.
  • Forfeiture of unutilised credit: Any Available R&D Tax Credit that has not yet been utilised (including any carried forward) is permanently forfeited — it cannot be applied against future liabilities.
  • No offsetting other reliefs: Any other tax relief that the Qualifying Entity might otherwise have been entitled to apply against the clawed-back amount is denied. The full repayment amount stands without offset.
  • Penalties treated as Due Tax: Any penalties arising from the claw-back are classified as Due Tax for purposes of the CT Law, attracting the UAE's standard late payment and non-payment consequences.

Article 15: Anti-Fragmentation — The FTA's Power to Counteract Artificial Separation

Article 15 targets a specific avoidance strategy: the deliberate artificial fragmentation of a business into multiple entities specifically designed to access the R&D Tax Credit in a way that would not have been possible had the business remained unified.

Article 15

Anti-Fragmentation Rule

The rule: Where the FTA determines that a Qualifying Entity or a person connected to it has artificially separated a business or part of a business — with the primary or principal purpose of accessing the R&D Tax Credit in a manner inconsistent with the intent of the legislation — the FTA has authority to take counteraction to neutralise the benefit obtained and claw back any credits obtained through the artificial arrangement.

What triggers scrutiny: The FTA is likely to apply enhanced scrutiny where multiple related entities each separately claim R&D Tax Credits for activities that, viewed together, appear to be a unified R&D programme that would have exceeded the AED 5M cap if conducted within a single entity. The fragmentation into multiple entities each below the cap, without genuine commercial substance for the separation, is the paradigm case.

What is not fragmentation: Genuine corporate structures with commercial substance — separate entities pursuing independent R&D programmes, distinct product lines or separate technology tracks — are not targeted by this rule. The anti-fragmentation rule is directed at arrangements lacking genuine commercial rationale beyond credit maximisation.

⚡ High-Risk Fragmentation Patterns — FTA Focus Areas

  • Multiple entities each spending just below AED 5M on what is effectively a single R&D programme
  • Newly incorporated entities with no genuine operational independence from the parent
  • Staff shared across entities where no genuine cost allocation or employment structure exists
  • R&D projects split across entities without separate management, IP ownership or distinct commercial objectives
  • Structures where the primary documented reason for separation is credit optimisation rather than commercial necessity

Article 16: The 5-Year Anti-Abuse Claw-Back Window

Article 16 is the broadest and most far-reaching post-claim rule in Ministerial Decision No. 24 of 2026. It creates a 5-year window during which the FTA may claw back R&D Tax Credits — both utilised and unutilised — if the Qualifying Entity undergoes one of six triggering events.

Article 16

5-Year Anti-Abuse Claw-Back Triggers

The FTA may claw back the R&D Tax Credit if, within five years of the end of the tax period in which the credit arose, the Qualifying Entity undergoes any of the following:

Claw-Back Trigger Risk Level Practical Notes
Ceases to be a Taxable Person (deregistration from UAE CT) High Risk Applies to voluntary deregistration and to entities that otherwise lose Taxable Person status. Plan the 5-year window before initiating deregistration.
Becomes a Qualifying Free Zone Person (QFZP) High Risk Switching to QFZP status after claiming R&D credits as a standard 9% taxpayer triggers claw-back. This is a critical planning point for mainland-to-free-zone migration strategies.
Elects to apply Small Business Relief (SBR) Moderate Risk Electing SBR within 5 years of claiming the credit triggers claw-back. Businesses with revenue below the SBR threshold should be advised not to elect SBR if they hold significant R&D Tax Credit balances.
Enters liquidation or winding up High Risk Applicable to both voluntary and compulsory liquidation. Liquidating entities within 5 years of an R&D credit will face the claw-back as part of the tax settlement process.
Redomiciles outside the UAE High Risk Any redomiciliation that moves the entity's tax residency outside the UAE within the 5-year window triggers claw-back of all credits arising in that period.

The Qualifying Restructuring Exception

Not all post-claim events trigger Article 16 claw-back. Where the triggering event arises as part of a qualifying business restructuring under Article 7, the anti-abuse claw-back does not apply — provided the 2-year activity continuation requirement is met and the restructuring has genuine commercial substance. This exception is the reason why properly structured and documented corporate reorganisations can be protected from Article 16, while opportunistic regime switches or substance-free migrations cannot.

🔵 What Happens to Utilised Credits Under Article 16 Claw-Back?

Article 16 claw-back applies to both utilised and unutilised credits. This means repayment is required even for credits that have already been offset against Corporate Tax in prior years — not just for carry-forward balances. The financial exposure includes late payment surcharges and penalties treated as Due Tax, making the 5-year window a significant ongoing liability that must be tracked throughout its duration.

Putting It All Together: The Post-Claim Risk Matrix

The following table summarises the risk events, the applicable article and the consequence for UAE R&D Tax Credit holders:

Event Article Consequence Window
Ownership change >50%, business activity changes Art. 5 Carry-forward credit lost — cannot be utilised Ongoing
Transferred credit not used in receipt period Art. 6 Transferred credit forfeited — no carry-forward for transferee End of period
R&D activities discontinued within 2 years post-restructuring Art. 7 Full claw-back (utilised + unutilised) + penalties as Due Tax + no offsetting reliefs 2 years post-restructuring
Artificial business fragmentation Art. 15 FTA counteraction — credits clawed back, arrangement nullified No fixed window
CT deregistration, QFZP election, SBR election, liquidation or redomiciliation Art. 16 Full claw-back of all credits from that tax period + penalties as Due Tax 5 years from credit period

How Fastlane Protects Your R&D Tax Credit After the Claim

Fastlane provides comprehensive post-claim R&D Tax Credit monitoring as part of our Corporate Tax advisory engagement. This includes:

  • Available credit tracking: We maintain a running balance of your Available R&D Tax Credit across periods, including carry-forward amounts and transfer history.
  • Ownership continuity monitoring: As part of your annual CT filing engagement, we assess whether the carry-forward conditions under Article 5 are satisfied before including carried-forward credits in the return.
  • Pre-transaction risk assessments: For any proposed ownership change, restructuring, regime election or liquidation, we model the Article 7 and Article 16 exposure and advise on timing and structuring options before the transaction is completed.
  • Anti-fragmentation review: Where clients operate group structures with multiple R&D-active entities, we review the substance and commercial rationale of the structure against the Article 15 anti-fragmentation standard.
  • 7-year documentation retention: Our accounting team maintains all technical and financial documentation required to defend credits in the event of an FTA review within the statutory retention period.